Overview
S Ng-Yuen practices practicing medicine in Kuala Lumpur, Malaysia.
Their clinical expertise encompasses Hemangioma, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about S S. Ng-Yuen
Is S S. Ng-Yuen a top-rated expert for Hemangioma?
MediFind is an objective health platform that identifies experts based on real-world data. S S. Ng-Yuen is classified as an Experienced expert for Hemangioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does S S. Ng-Yuen participate in research or clinical trials?
Yes. S S. Ng-Yuen has published 8 articles and abstracts on conditions like Hemangioma. You can view a list of S S. Ng-Yuen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HemangiomaNg-Yuen isExperienced. Learn about Hemangioma.
- HistiocytosisNg-Yuen isExperienced. Learn about Histiocytosis.
- Non-Langerhans-Cell HistiocytosisNg-Yuen isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaNg-Yuen isExperienced. Learn about Reticulohistiocytoma.